BGI opening 2012

Company Profiles See all

BGI opening 2012

On March 3, 2011, a new research center--Danish Platform for Large-scale Sequencing and Bioinformaticsis to be funded with DKK 170 million by Danish National Advanced Technology Foundation (DKK 84 million), BGI (DKK 60 million) and other partners. This center aims to support development of cancer vaccines and Danish genome research. There are two projects in this platform: One project is to identify previously unknown pathogens that will lead to the development and patenting of commercial vaccines. The second is to establish a unique catalogue of the millions of variations in Danes' DNA. BGI Europe (an overseas branch of BGI) situated at Copenhagen Bio Science Park (COBIS) will play an important role in the disease prevention and genome research.

The following article is quoted from the news release of University of Copenhagen:
http://news.ku.dk/all_news/2011/2011.3/majorgranttosupportdevelopmentofcancervaccine/

Company Profiles See all

Novo Seeds is a life science supporting program launched by the Novo Nordisk...

Lifandis links the industry to a wealth of biological samples from the...

HÅRklinikken UK 2013_0515
HÅRklinikken DK 2013_0515
Peter Rasborg fortæller om sin passion for revision og om at få tingene til...
      

Add a comment...

Name
E-mail
Web
Comment